Clinical Trial Update: Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for mirikizumab in the treatment of chronic inflammatory conditions of the ileal pouch; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pouchitis

Drugs mentioned

• Mirikizumab (mirikizumab)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Pouchitis, Pouches, Ileoanal | Phase 4 | Status: RECRUITING